GoldenGolden
Advanced Search
Enthera

Enthera

Enthera is an IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

January 2021
Enthera raises a $35,000,000 series A round from AbbVie Biotech Ventures, JDRF T1D Fund, Roche and Sofinnova Partners.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.